ALPORT SYNDROME
Clinical trials for ALPORT SYNDROME explained in plain language.
Never miss a new study
Get alerted when new ALPORT SYNDROME trials appear
Sign up with your email to follow new studies for ALPORT SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare kidney diseases in 2-Year drug trial
Disease control Recruiting nowThis study is testing an oral medication called sparsentan in children aged 1 to 18 with specific rare kidney diseases. The main goal is to see if the drug is safe and can reduce harmful protein loss in urine over 108 weeks. Researchers will enroll about 67 children to monitor th…
Matched conditions: ALPORT SYNDROME
Phase: PHASE2 • Sponsor: Travere Therapeutics, Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
Massive global effort launched to map rare kidney disease
Knowledge-focused Recruiting nowThis study aims to create a large international database to understand how Alport syndrome progresses over time in 700 patients. Researchers will track kidney function, hearing loss, eye problems, and quality of life to learn what factors predict kidney failure. The goal is to ga…
Matched conditions: ALPORT SYNDROME
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
New system aims to connect kidney patients with right clinical trials
Knowledge-focused Recruiting nowThis study tests a new system that helps match kidney disease patients with clinical trials that might be right for them. It works by analyzing patient information to find trials targeting their specific type of kidney condition. The study also measures how well patients understa…
Matched conditions: ALPORT SYNDROME
Phase: NA • Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC